REG - Primary Health Props - Board directorships

Primary Health PropertiesAnnouncement

Yesterday 14:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260420:nRST1677Ba&default-theme=true

RNS Number : 1677B  Primary Health Properties PLC  20 April 2026

Primary Health Properties PLC

(Incorporated in the United Kingdom)

Company Number: 3033634

LSE Share Code: PHP

JSE Share Code: PHP

ISIN Code: GB00BYRJ5J14

LEI: 213800Y5CJHXOATK7X11

("PHP" or the "Company")

 

20 April 2026

 

Board directorships

 

Primary Health Properties PLC (LSE: PHP), the UK's leading investor in
critical healthcare infrastructure, notes the announcement made earlier today
by Life Science REIT plc and British Land plc, under which Richard Howell,
Chief Financial Officer of PHP and formerly an independent non-executive
director of Life Science REIT plc has resigned from the board of directors of
Life Science REIT plc. This is effective today following the conclusion of the
Scheme of Arrangement of Life Science REIT plc and British Land plc.

 

For further information contact:

 

Mark Davies
CEO
Richard Howell CFO

Primary Health Properties
PLC
Primary Health Properties PLC

 

David Purcell Investor Relations

Primary Health Properties PLC

T: +44 (0) 7921 190 136

E: david.purcell@phpgroup.co.uk

 

Sodali & Co Financial PR

Elly Williamson/Louisa Henry/Saskia Bottomley

T: +44 (0) 207 250 1446 E: PHP@client.sodali.com

 

 

The Company has a primary listing on the London Stock Exchange and a secondary
listing on the JSE Limited.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNIMMBTMTATBLF



            Copyright 2019 Regulatory News Service, all rights reserved